Bisphosphonate-induced orbital inflammation.
Mbekeani
Joyce N
JN
Slamovits
Thomas L
TL
D017677:Age Distribution; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D054517:Orbital Cellulitis / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D055622:Orbital Myositis / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D010024:Osteoporosis / Q000188:drug therapy*; D056737:Safety-Based Drug Withdrawals; D017678:Sex Distribution
D050071:Bone Density Conservation Agents; D004164:Diphosphonates